August 25, 2025 a 09:01 pm
ALB: Analysts Ratings - Albemarle Corporation
Albemarle Corporation, a leading player in the specialty chemicals market, shows a varied landscape in analyst ratings. Over recent months, the company has experienced a notable shift in sentiment with an increased count in 'Hold' ratings, reflecting a cautious stance among analysts. Despite its strongholds in lithium and bromine segments, uncertainty appears to linger in the eyes of market experts.
Historical Stock Grades
Analyzing the latest analyst data for Albemarle Corporation, it's evident that sentiment has shifted significantly over time. The current ratings as of August 2025 are as follows:
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 6 | |
| Hold | 15 | |
| Sell | 3 | |
| Strong Sell | 0 |
Sentiment development
- Over the past year, the total number of analyst ratings has slightly increased, indicating greater coverage and interest in Albemarle.
- A prominent trend is the rise in 'Hold' ratings, suggesting analysts recommend investors to wait for more clarity before making further decisions.
- 'Strong Buy' ratings have decreased notably from mid-2024 to mid-2025, with analysts showing growing caution.
Percentage trends
- From August 2024 to August 2025, the percentage of 'Strong Buy' ratings decreased from 15% to about 6%.
- 'Hold' ratings now constitute the majority, reaching around 50% of total ratings, illustrating increased restraint among analysts.
- The decline in 'Strong Buy' and 'Buy' ratings indicates a shift towards neutrality and possible market uncertainties.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-18 | Neutral | Neutral | JP Morgan |
| 2025-08-01 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-08-01 | Sector Perform | Sector Perform | Scotiabank |
| 2025-07-31 | Sell | Sell | UBS |
| 2025-07-30 | Sector Weight | Overweight | Keybanc |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-30 | Sector Weight | Overweight | Keybanc |
| 2025-07-29 | Underperform | Neutral | Baird |
| 2025-07-11 | Sell | Neutral | UBS |
| 2024-08-05 | Neutral | Outperform | Baird |
| 2024-07-31 | Hold | Buy | Berenberg |
Interpretation
The current analyst sentiment towards Albemarle Corporation signals a cautious and risk-averse market view. The rise in 'Hold' ratings suggests analysts are advising investors to exercise patience as future market conditions remain unclear. The substantial decrease in 'Strong Buy' and 'Buy' ratings could imply a period of consolidation or a reevaluation of the company's growth prospects. Consequently, while Albemarle's market fundamentals remain robust, the analyst community exhibits a conservative outlook.
Conclusion
Albemarle Corporation's analyst sentiment reflects a complex interplay of potential market challenges and inherent capabilities. While the immediate outlook appears conservative due to a growing number of 'Hold' recommendations, it does not negate the intrinsic value proposition of its diversified chemical segments. Investors should weigh Albemarle's long-term growth potential against the backdrop of evolving industry dynamics. The sentiment shift underlines a balanced approach, highlighting the need for adaptive strategies tailored to market fluctuations.